Artelo Biosciences
ARTL
13 hedge funds and large institutions have $1.57M invested in Artelo Biosciences in 2021 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 3 closing their positions.
20% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 5
3.86% less ownership
Funds ownership: 11.97% → 8.11% (-3.9%)
19% less funds holding
Funds holding: 16 → 13 (-3)
52% less capital invested
Capital invested by funds: $3.29M → $1.57M (-$1.72M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Northern Trust
Chicago,
Illinois
|
+$48K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$20.6K |
| 3 |
VF
Virtu Financial
New York
|
+$20.6K |
| 4 |
HighTower Advisors
Chicago,
Illinois
|
+$9.14K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$6.86K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$258K |
| 2 |
Two Sigma Advisers
New York
|
-$210K |
| 3 |
Two Sigma Investments
New York
|
-$195K |
| 4 |
BFM
Boothbay Fund Management
New York
|
-$112K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$45.7K |
ARTL Hedge Fund Activity: Q3 2021 in Review
13 of the 5,729 institutional investors tracked by Wall St. Rank reported a position in Artelo Biosciences (ARTL) for Q3 2021, worth a combined $1.57M — down 52% from $3.29M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of ARTL and 0 opened new positions — a net loss of 3 holders — while 5 trimmed existing stakes and 6 added.
The largest buyer was Northern Trust, adding an estimated $48K. The largest seller was Renaissance Technologies, cutting an estimated $258K.
- 13 institutional investors held Artelo Biosciences (ARTL) as of Q3 2021, down from 16 in Q2 2021.
- Funds reported $1.57M of Artelo Biosciences stock for Q3 2021, down 52% quarter-over-quarter.
- 0 funds opened new Artelo Biosciences positions in Q3 2021 and 3 closed out, a net change of -3 holders.
- The largest Artelo Biosciences buyer in Q3 2021 was Northern Trust, an estimated $48K added.
- The largest Artelo Biosciences seller in Q3 2021 was Renaissance Technologies, an estimated $258K sold.
Based on aggregated 13F filings for Q3 2021.